Open Access

Enhancing the evidence: latest real-world insights into NOACs for atrial fibrillation

Event: ESC Congress 2022
Topic: Stroke Prevention
Session type: Satellite Symposium
Sponsored by Boehringer Ingelheim
Date: 28 August 2022
Time: 17:45 - 18:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

Real-world evidence: a bridge between trials and clinical practice.

Speaker: Doctor J. Halperin (New York, US)
Thumbnail

What do real-world analyses tell us about NOACs?

Speaker: Professor M. Huisman (Leiden, NL)
Thumbnail

GLORIA-AF: new Phase III data from this innovative registry program.

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

Panel discussion on NOACs and real-world evidence.

Speaker: Doctor J. Halperin (New York, US)
Speaker: Professor G. Lip (Liverpool, GB)
Speaker: Professor M. Huisman (Leiden, NL)
Thumbnail

6 speakers from this session

Doctor Jonathan Halperin

Mount Sinai Medical Center, New York (United States of America)
11 presentations
0 follower

Professor Menno Huisman

Leiden University Medical Center, Leiden (Netherlands (The))
8 presentations
0 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
71 presentations
5 followers

Doctor Jonathan Halperin

Mount Sinai Medical Center, New York (United States of America)
11 presentations
0 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
71 presentations
5 followers

Professor Menno Huisman

Leiden University Medical Center, Leiden (Netherlands (The))
8 presentations
0 follower

This platform is supported by

logo Novo Nordisk